• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,524.26 -719.08
( -0.97%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
63,697.20 -2,890.92
(-4.34%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Bafna Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532989
INE878I01022
40.6429546
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BAFNAPH
38.11
422.86
EPS(TTM)
Face Value()
Div & Yield %
4.69
10
0
 

As on: Jun 08, 2026 08:08 PM



Particulars
Company Name Bafna Pharmaceuticals Ltd
Face Value 10
BSE Code 532989
Year End 202603
Full Year
Equity ( in Cr.) 23.66
B.V. 40.60
Sales in Cr. 150.62
NP in Cr. 11.10
NP Var% 74.00
Div% 0.00
CPS 7.30
EPS 4.70
Traded Value( in Lakhs) 10.53
52 Week High 205.00
52 Week Low 72.00
Price BSE 179.00
Price NSE 176.00
Market Capital( in Cr.) 422.86
P/C Ratio 24.70
P/E Ratio 38.10
Price Vs.BV 4.41
Latest Quarter
Year End 202603
Sales in Cr. 42.24
NP in Cr. 2.75
NP Var % -11.00
Trailing Twelve Months
Year End 202603
Sales 143.45
OPM 3.81
NP 0.75
NP Var% 74.18
EPS 4.69
PE 38.11